Skip to main content
. 2017 Jul 5;8(34):57278–57301. doi: 10.18632/oncotarget.18985

Table 7. KNN classification-based predictions of pathological categories with subsets of 30,000 cells and Biomarkers I.

A Classification
ID B ASAP AC Stage II Stage III LAC Total
HPrEpiC 1,613 20 221 35 16 106 2,011
% 80.21 0.99 10.99 1.74 0.8 5.27 100
LNCaP 78 262 430 14,681 264 1,220 16,935
% 0.46 1.55 2.54 86.69 1.56 7.2 100
B Classification
ID B ASAP AC Stage II Stage III LAC Total
Patient 5 0 1 24 7,693 878 2,716 11,312
% 0 0.01 0.21 68.01 7.76 24.01 100
Patient Z 201 1,062 35 3,935 265 3,415 8,913
% 2.26 11.92 0.39 44.15 2.97 38.31 100
C Classification
Phase B ASAP AC Stage II Stage III LAC Total
B1 277 131 416 453 56 1,102 2,435
% 11.38 5.38 17.08 18.6 2.3 45.26 100
P 330 443 263 6,164 1,705 7,874 16,779
% 1.97 2.64 1.57 36.74 10.16 46.93 100
D Classification
ID B ASAP AC Stage II Stage III LAC Total
Patient 7 7 11 32 1,568 411 3,495 5,524
% 0.13 0.2 0.58 28.39 7.44 63.27 100
Patient 8 142 140 578 2,291 1,779 2,968 7,898
% 1.8 1.77 7.32 29.01 22.52 37.58 100